6Olsen KM,Devlin JW.Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients[J].Aliment Pharmacol Ther,2008;28(3):326-33.
7Cheng HC,Chang WL,Yeh YC,et al.Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities[J].Gastrointest Endosc,2009;70(3):433-9.
4Lee D Y, Shin H S, Lee I, et al. Pharmacokinetics of ome- prazole in rats with water deprivation for 72 hours[J]. Biop- harm Drug Dispos, 20116, 27(8):361 370.
5Jia H, Li W, Zhao K. Determination of omeprazole in rat plas ma by high performance liquid chromatography without sol- vent extraction[J]. J Chrornatogr B Analyt Technol Biomed Life Sci, 2006, 837(1-2) : 112 115.
6Dae Y L, Inchul L, Myung G L. Pharmacokinetics of ome prazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine[J]. Inter J Pharm, 2007, 330:37-44.
7De Paepe P, Belpaire F M, Rosseel M T, et al. The influence of hemorrhagic shock on the pharmacokinetics and the analge sic effect of morphine in the rat[J]. Fundam Clin Pharmacol, 1998, 12(6):624 630.
8Lonati C, Sordi A, Giuliani D, et al. Molecular changes in- duced in rat liver by hemorrhage and effects of melanoeortin treatment[J]. Anesthesiology, 2012, 116(3) :692 700.
9Johnson KB, Egan TD, Kern SE, etal. The influence of hem- orrhagic shock on propofol: a pharmacokinetic and pharmaco dynamic analysis[J]. Anesthesiology, 2003, 99(2):409 420.
10Regardh CG, Gabrielsson M, Hoffman KJ, et al. Pharmaco kinetics and metabolism of omeprazole in animals and man an overview[J]. Stand J Gastroenterol Suppl, 1985, 108 79-94.
